4basebio PLC (LON:4BB – Get Free Report) insider Amy Walker bought 1,151 shares of the company’s stock in a transaction dated Friday, February 28th. The stock was purchased at an average cost of GBX 1,120 ($14.44) per share, for a total transaction of £12,891.20 ($16,616.65).
4basebio Stock Up 0.4 %
Shares of LON:4BB opened at GBX 1,120 ($14.44) on Thursday. The firm has a 50 day simple moving average of GBX 1,175.06 and a 200 day simple moving average of GBX 1,276.57. 4basebio PLC has a 52 week low of GBX 832.50 ($10.73) and a 52 week high of GBX 1,820 ($23.46). The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The company has a market cap of £143.47 million, a PE ratio of -1,435.90 and a beta of 1.09.
4basebio Company Profile
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
See Also
- Five stocks we like better than 4basebio
- Stock Sentiment Analysis: How it Works
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to Profit From Growth Investing
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- The Most Important Warren Buffett Stock for Investors: His Own
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for 4basebio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4basebio and related companies with MarketBeat.com's FREE daily email newsletter.
